{"id":8238,"date":"2021-12-16T12:25:53","date_gmt":"2021-12-16T17:25:53","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/abaloparatida-cas-247062-33-5-de-grado-superior-para-una-tasa-de-fracturas-reducida-y-una-incidencia-de-hipercalcemia\/"},"modified":"2021-12-16T12:25:53","modified_gmt":"2021-12-16T17:25:53","slug":"abaloparatida-cas-247062-33-5-de-grado-superior-para-una-tasa-de-fracturas-reducida-y-una-incidencia-de-hipercalcemia","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/es\/product\/abaloparatida-cas-247062-33-5-de-grado-superior-para-una-tasa-de-fracturas-reducida-y-una-incidencia-de-hipercalcemia\/","title":{"rendered":"Abaloparatida CAS 247062-33-5 de grado superior para una tasa de fracturas reducida y una incidencia de hipercalcemia"},"content":{"rendered":"

Abaloparatida CAS 247062-33-5 de grado superior para una tasa de fracturas reducida y una incidencia de hipercalcemia<\/strong><\/h2>\n

Nombre del producto: Abaloparatide
\n Secuencia: H-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu- Arg-Arg-Arg-Glu-Leu-Leu-Glu-Lys-Leu-Leu-N-Me-Ala-Lys- Leu-His-Thr-Ala-NH2
\n Sin\u00f3nimos: Abaloparatide
\n CAS: 247062- 33-5
\n MF: C174H300N56O49
\n MW: 3960.5896
\n EINECS:
\n Categor\u00edas de productos:
\n Mol Archivo: 247062-33-5.mol <\/p>\n

Abaloparatide, un activador selectivo del receptor de la hormona paratiroidea (receptor PTH1), ha avanzado en el desarrollo cl\u00ednico para el tratamiento de la osteoporosis en mujeres posmenop\u00e1usicas con alto riesgo de fractura debido a su buena actividad osteog\u00e9nica, elaborado a partir de abaloparatida. <\/p>\n

\u00cdndice t\u00e9cnico de Abaloparatida CAS 247062-33-5<\/strong>
\n Aspecto: Polvo blanco
\n Pureza (HPLC) \u226598.0%
\n Contenido de acetato 5.0% ~ 12.0%
\n Contenido de agua \u22648.0%
\n Contenido de p\u00e9ptido \u226580.0%
\n Embalaje y transporte:
\n Baja temperatura, envasado al vac\u00edo, con precisi\u00f3n de mg a pedido. <\/p>\n

Funci\u00f3n y aplicaci\u00f3n de abaloparatida CAS 247062-33-5<\/strong>
\n Abaparatida, un p\u00e9ptido que consiste de 34 residuos de amino\u00e1cidos, es un nuevo p\u00e9ptido relacionado con la hormona paratiroidea (PTHrP) desarrollado por RadiusHealth, que es un activador potente y selectivo del receptor PTH-I para aumentar el contenido mineral \u00f3seo, la densidad \u00f3sea y la resistencia \u00f3sea y promover la formaci\u00f3n \u00f3sea , y ha sido aprobado para su comercializaci\u00f3n por la FDA en April Chemicalbook28, 2017. Aprobado para su comercializaci\u00f3n por la FDA el 28 de abril de 2017 bajo el nombre comercial Tymlos.Abapatide se administra por v\u00eda subcut\u00e1nea para el tratamiento de la osteoporosis en mujeres posmenop\u00e1usicas que est\u00e1n en riesgo de fracturas o que no han respondido a otros agentes terap\u00e9uticos, y es eficaz para reducir la tasa de nuevas fracturas vertebrales y no vertebrales. La abapatida es m\u00e1s capaz de reducir las tasas de fracturas y las tasas de hipercalcemia en comparaci\u00f3n con la teriparatida.<\/p>\n","protected":false},"excerpt":{"rendered":"

Nombre del producto: Abaloparatide
\n CAS: 247062-33-5
\n MF: C174H300N56O49
\n MW: 3960.5896
\n Mol Archivo: 247062-33-5.mol<\/p>\n","protected":false},"featured_media":2174,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[],"product_tag":[1422],"class_list":{"0":"post-8238","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_tag-top-grade-abaloparatide-cas-247062-33-5-for-reduced-fracture-rate-and-hypercalcemia-incidence-es","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product\/8238","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/comments?post=8238"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/media\/2174"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/media?parent=8238"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_brand?post=8238"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_cat?post=8238"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/es\/wp-json\/wp\/v2\/product_tag?post=8238"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}